Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 1.66
(3.75%)
HKD 1.66
(3.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 23.59 Million | 24.25 Million | 15.94 Million | 9.71 Million | 8.73 Million |
| Gross Profit | -23.59 Million | -24.25 Million | -15.94 Million | -9.71 Million | -8.73 Million |
| Operating Expenses | 158.31 Million | 269.02 Million | 477.76 Million | 358.33 Million | 19.92 Million |
| Selling, General and Administrative Expenses | 49.34 Million | 100.29 Million | 229.47 Million | 91.22 Million | 3.63 Million |
| Research and Development Expenses | 111.74 Million | 168.73 Million | 248.29 Million | 267.11 Million | 16.28 Million |
| Other Expenses | -2.77 Million | -50 Thousand | 278 Thousand | 193 Thousand | - |
| Cost and Expenses | 163.67 Million | 293.27 Million | 493.71 Million | 368.04 Million | 28.65 Million |
| Operating Income | -181.9 Million | -293.27 Million | -493.71 Million | -368.04 Million | -28.65 Million |
| Interest Expense | 578 Thousand | 959 Thousand | 685 Thousand | 56 Thousand | - |
| Income Tax Expense | 5.54 Million | -29.3 Million | -58.3 Million | -16.59 Million | 3.00 |
| Earnings before Tax | -188.82 Million | -266.8 Million | -493.92 Million | -382.38 Million | -26.89 Million |
| Net Income | -194.36 Million | -237.5 Million | -435.62 Million | -365.78 Million | -26.89 Million |
| Earnings Per Share Basic | -0.80 | -0.98 | -1.79 | -1.50 | -0.11 |
| Earnings Per Share Diluted | -0.80 | -0.98 | -1.79 | -1.50 | -0.11 |
| Weighted Average Shares Outstanding | 243.41 Million | 243.41 Million | 243.93 Million | 243.93 Million | 243.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 243.41 Million | 243.41 Million | 243.93 Million | 243.93 Million | 243.93 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -158.31 Million | -209.05 Million | -477.76 Million | -358.33 Million | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | 9.61 Million | 23.59 Million | - | 14.08 Million |
| Gross Profit | - | - | -9.61 Million | -23.59 Million | - | -14.08 Million |
| Operating Expenses | 15.51 Million | 15.64 Million | 35.87 Million | 158.31 Million | 51.41 Million | 52.03 Million |
| Selling, General and Administrative Expenses | 3.8 Million | 3.83 Million | 12.08 Million | - | 11.78 Million | 16.69 Million |
| Research and Development Expenses | 11.7 Million | 11.8 Million | 23.78 Million | - | 23.19 Million | 36.98 Million |
| Other Expenses | - | - | - | -42 Thousand | - | - |
| Cost and Expenses | 15.51 Million | 15.64 Million | 35.87 Million | 181.9 Million | 51.41 Million | 52.03 Million |
| Operating Income | -15.51 Million | -15.64 Million | -35.87 Million | -181.9 Million | -34.97 Million | -53.67 Million |
| Interest Expense | - | - | 202.02 Thousand | 578 Thousand | - | 442.2 Thousand |
| Income Tax Expense | -1.34 Million | -1.35 Million | -3.72 Million | -12.47 Million | -2.14 Million | -8.87 Million |
| Earnings before Tax | -15.21 Million | -15.34 Million | -51.54 Million | -206.84 Million | -50.25 Million | -51.36 Million |
| Net Income | -13.87 Million | -13.99 Million | -49.34 Million | -194.36 Million | -48.1 Million | -46.53 Million |
| Earnings Per Share Basic | -0.06 | -0.06 | -0.20 | - | -0.20 | -0.19 |
| Earnings Per Share Diluted | -0.06 | -0.06 | -0.20 | - | -0.20 | -0.19 |
| Weighted Average Shares Outstanding | 243.41 Million | 243.41 Million | 243.41 Million | 243.41 Million | 243.41 Million | 243.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 243.41 Million | 243.41 Million | 243.41 Million | 243.41 Million | 243.41 Million | 243.41 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -13.68 Million | -13.8 Million | -32.01 Million | - | -31.21 Million | -48.55 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
600483
002383
KTTA
0737
6147
PIKK